Citations

Mayo Clinic

Showing 10 of 108602 citations.

Pharmacogenomics and beyond! Customized pharmacotherapy for solid organ transplant recipients
Lemke, Adley , Wright, Jessica , May, Heather P. , Personett, Heather A. , Wright, Jessica A , Lemke, Adley I

Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy | March 31, 2023 | Volume: 43 | Issue: 7 | Pages: 596-608

10.1002/phar.2798 | PMID 36999337 Get It

AbstractSolid organ transplant recipients are reliant on immunosuppressive drugs, which have a narrow therapeutic index, and are concurrently vulnerable to adverse drug events due to comorbidity burden and the complexity of their medication regimens. Urgent management of post‐transplant complications often falls to the generalist clinician or critical care specialist. The purpose of this narrative review is to discuss innovations and bedside applications of pharmacogenomics and therapeutic drug monitoring applied to immunosuppression and agents frequently encountered in transplant recipients. Medication formulations will be given specific attention, as interchange is frequently required in the acute care setting. Bioassays quantifying immune system activity will be described with practical applications. A structured approach to addressing drug–drug, drug‐gene, and drug–drug‐gene interactions will be modeled using a case‐based approach synthesizing pharmacogenomics, therapeutic drug monitoring, pharmacokinetics, and pharmacodynamic principles.
Fever, Cough, and Pancytopenia in a Transplant Recipient
Higgins, Eibhlin , Yuan, Ji, Lange, Sawyer, Boilson, Barry A. , Pritt, Bobbi S. , Rizza, Stacey A. , Ji, Yuan , Pritt, Bobbi S , Yuan, Ji

Clinical Infectious Diseases | March 31, 2023 | Volume: 77 | Issue: 7 | Pages: 1065-1067

10.1093/cid/ciad167 | PMID 37796055 Get It

Periodic limb movements in sleep are associated with hippocampal atrophy in stroke-free community-dwelling older adults
Brutto, Óscar H. Del , Mera, Robertino M. , Castillo, Pablo R. , Del Brutto, Oscar H , Castillo, Pablo R , Rumbea, Denisse A.

SLEEP | March 31, 2023 | Volume: 46 | Issue: 6 | Pages: No page available

10.1093/sleep/zsad088 | PMID 36995971 Get It

Evidence-based consensus guidelines on patient selection and trial stimulation for spinal cord stimulation therapy for chronic non-cancer pain
Shanthanna, Harsha , Provenzano, David , Bouche, Bénédicte , Buchser, Eric, Chadwick, Raymond , Doshi, Tina L , Duarte, Rui , Hunt, Christine , Huygen, Frank , Knight, Judy, Kohan, Lynn , North, Richard B. , Winfree, Christopher J., Provenzano, David Anthony , Doshi, Tina L , Duarte, Rui , Hunt, Christine , Narouze, Samer , Shanthanna, Harsha , Eldabe, Sam S. , Rosenow, Joshua M. , Narouze, Samer

Regional Anesthesia & Pain Medicine | March 31, 2023 | Volume: 48 | Issue: 6 | Pages: 273-287

10.1136/rapm-2022-104097 | PMID 37001888 Get It

Spinal cord stimulation (SCS) has demonstrated effectiveness for neuropathic pain. Unfortunately, some patients report inadequate long-term pain relief. Patient selection is emphasized for this therapy; however, the prognostic capabilities and deployment strategies of existing selection techniques, including an SCS trial, have been questioned. After approval by the Board of Directors of the American Society of Regional Anesthesia and Pain Medicine, a steering committee was formed to develop evidence-based guidelines for patient selection and the role of an SCS trial. Representatives of professional organizations with clinical expertize were invited to participate as committee members. A comprehensive literature review was carried out by the steering committee, and the results organized into narrative reports, which were circulated to all the committee members. Individual statements and recommendations within each of seven sections were formulated by the steering committee and circulated to members for voting. We used a modified Delphi method wherein drafts were circulated to each member in a blinded fashion for voting. Comments were incorporated in the subsequent revisions, which were recirculated for voting to achieve consensus. Seven sections with a total of 39 recommendations were approved with 100% consensus from all the members. Sections included definitions and terminology of SCS trial; benefits of SCS trial; screening for psychosocial characteristics; patient perceptions on SCS therapy and the use of trial; other patient predictors of SCS therapy; conduct of SCS trials; and evaluation of SCS trials including minimum criteria for success. Recommendations included that SCS trial should be performed before a definitive SCS implant except in anginal pain (grade B). All patients must be screened with an objective validated instrument for psychosocial factors, and this must include depression (grade B). Despite some limitations, a trial helps patient selection and provides patients with an opportunity to experience the therapy. These recommendations are expected to guide practicing physicians and other stakeholders and should not be mistaken as practice standards. Physicians should continue to make their best judgment based on individual patient considerations and preferences.
Role of patient selection and trial stimulation for spinal cord stimulation therapy for chronic non-cancer pain: a comprehensive narrative review
Shanthanna, Harsha , Provenzano, David Anthony, Kashir, Imad, Goel, Akash , Tian, Chenchen , Couban, Rachel , Levit, Tal , Provenzano, David Anthony , Hagedorn, Jonathan M , Narouze, Samer , Shanthanna, Harsha , Eldabe, Sam S. , Chang, Yaping , Adams, Daniel, Tian, Chenchen, Hagedorn, Jonathan M. , Narouze, Samer

Regional Anesthesia & Pain Medicine | March 31, 2023 | Volume: 48 | Issue: 6 | Pages: 251-272

10.1136/rapm-2022-103820 | PMID 37001887 Get It

Background/importance Patient selection for spinal cord stimulation (SCS) therapy is crucial and is traditionally performed with clinical selection followed by a screening trial. The factors influencing patient selection and the importance of trialing have not been systematically evaluated. Objective We report a narrative review conducted to synthesize evidence regarding patient selection and the role of SCS trials. Evidence review Medline, EMBASE and Cochrane databases were searched for reports (any design) of SCS in adult patients, from their inception until March 30, 2022. Study selection and data extraction were carried out using DistillerSR. Data were organized into tables and narrative summaries, categorized by study design. Importance of patient variables and trialing was considered by looking at their influence on the long-term therapy success. Findings Among 7321 citations, 201 reports consisting of 60 systematic reviews, 36 randomized controlled trials (RCTs), 41 observational studies (OSs), 51 registry-based reports, and 13 case reports on complications during trialing were included. Based on RCTs and OSs, the median trial success rate was 72% and 82%, and therapy success was 65% and 61% at 12 months, respectively. Although several psychological and non-psychological determinants have been investigated, studies do not report a consistent approach to patient selection. Among psychological factors, untreated depression was associated with poor long-term outcomes, but the effect of others was inconsistent. Most RCTs except for chronic angina involved trialing and only one RCT compared patient selection with or without trial. The median (range) trial duration was 10 (0–30) and 7 (0–56) days among RCTs and OSs, respectively. Conclusions Due to lack of a consistent approach to identify responders for SCS therapy, trialing complements patient selection to exclude patients who do not find the therapy helpful and/or intolerant of the SCS system. However, more rigorous and large studies are necessary to better evaluate its role.
Thyroid Disease, Hypertension, and Pregnancy: The Need for Balance Illustrated in 2 Cases
Sousa, Círia, Kattah, Andrea G. , Stan, Marius, Kattah, Andrea, Garovic, Vesna D. , Stan, Marius N. , Fervenza, Fernando C.

American Journal of Hypertension | March 30, 2023 | Volume: 36 | Issue: 7 | Pages: 411-414

10.1093/ajh/hpad030 | PMID 36996311 Get It

Abstract Thyroid dysfunction in pregnancy has been associated with hypertensive disorders of pregnancy and poor maternal and fetal outcomes. In this article, we describe two cases of significant thyroid dysfunction leading to new diagnoses of chronic hypertension in pregnancy and review physiologic changes in the thyroid gland, placenta and maternal cardiovascular system during pregnancy.
Anatomical Step-by-Step Dissection of Complex Skull Base Approaches for Trainees: Surgical Anatomy of the Frontotemporal and Orbitozygomatic Craniotomies
Carlstrom, Lucas P. , Graffeo, Christopher S. , Leonel, Luciano CPC, Perry, Avital , Link, Michael J. , Peris-Celda, Maria, Leonel, Luciano P.C., Peris‐Celda, Maria

Journal of Neurological Surgery Part B: Skull Base | March 30, 2023 | Volume: 85 | Issue: 04 | Pages: 370-380

10.1055/a-2065-9495 | PMID 38966301 Get It

Abstract Introduction Although many neuroanatomic atlases have been published, few have detailed complex cranial approaches and pertinent anatomic considerations in a stepwise fashion intended for rapid comprehension by neurosurgery students, residents, and fellows. Methods Five sides of formalin-fixed latex-injected specimens were dissected under microscopic magnification. The frontotemporal and orbitozygomatic approaches were performed by neurosurgical residents and fellows at different training levels with limited previous experience in anatomical dissection mentored by the senior authors (M.P.C. and M.J.L.). Meticulous surgical anatomic dissections were performed until sufficient visual and technical completion was attained, with parameters of effectively demonstrating key surgical steps for educational training purposes. Following the completion of dissection and three-dimensional photography, illustrative case examples were reviewed to demonstrate the relative benefits and optimal applications of each approach. Results The frontotemporal and orbitozygomatic approaches afford excellent access to anterior and middle skull base pathologies, as well as the exposure of the infratemporal fossa. Key considerations include head positioning, skin incision, scalp retraction, fat pad dissection and facial nerve protection, true or false MacCarty keyhole fashioning, sphenoid wing drilling and anterior clinoidectomy, completion of the craniotomy and accessory orbital osteotomy cuts, dural opening, and intradural neurovascular access. Conclusion The frontotemporal and orbitozygomatic approaches are core craniotomies that offer distinct advantages for complex cranial operations. Learning and internalizing their key steps and nuanced applications in a clinical context is critical for trainees of many levels. The orbitozygomatic craniotomy in particular is a versatile but challenging approach; operative-style laboratory dissection is an essential component of its mastery and one that will be powerfully enhanced by the current work.
Utilization and reimbursement trends of osteopathic manipulative treatment for Medicare patients: 2000–2019
Starr, Evan G. , Hanson, Romney B. , Woolstenhulme, Jonathan B. , Roush, Andrew J. , Sperry, Nathan B., Wilde, Benjamin, Zapata, Isain , Smith, Jacob F. , Brooks, Amanda E.

Journal of Osteopathic Medicine | March 30, 2023 | Volume: 123 | Issue: 6 | Pages: 309-315

10.1515/jom-2022-0174 | PMID 36996336 Get It

Abstract Context Osteopathic manipulative treatment (OMT) has been established as a beneficial and noninvasive treatment option for multiple conditions. With the total number of osteopathic providers tripling and the subsequent increase in osteopathic physician representation, we would expect the clinical use of OMT to increase accordingly. Objectives To that end, we evaluated the utilization and reimbursement of OMT services among Medicare beneficiaries. Methods Current procedural terminology (CPT) codes 98925 to 98929 were accessed from the Center for Medicare and Medicaid Services (CMS) from 2000 to 2019. These codes indicate OMT treatment, 98925 (1–2 body regions treated), 98926 (3–4 body regions treated), 98927 (5–6 body regions treated), 98928 (7–8 body regions treated), and 98929 (9–10 body regions treated). Monetary reimbursement from Medicare was adjusted for inflation, and total code volume was scaled to codes per 10,000 beneficiaries to account for the increase in Medicare enrollment. Results Overall OMT utilization declined between 2000 and 2019 by 24.5%. A significant downward trend in the utilization of CPT codes for OMT involving fewer body regions (98925–98927) was observed, and was contrasted by a slight upward trend in the use of codes for more body regions (98928, 98929). The adjusted sum reimbursement of all codes decreased by 23.2%. Lower value codes showed a higher rate of decline, whereas higher value codes changed less dramatically. Conclusions We conjecture that lower remuneration for OMT has disincentivized physicians financially and may have contributed to the overall decline in OMT utilization among Medicare patients, along with a decreased number of residencies offering specific training in OMT, and increased billing complexity. In considering the upward trend of higher-value code usage, it is possible that some physicians are increasing the comprehensiveness of their physical assessment and associated OMT to reduce the overall financial impact of reimbursement cuts.
American College of Sports Medicine (ACSM) International Multidisciplinary Roundtable report on physical activity and nonalcoholic fatty liver disease
Stine, Jonathan G. , Long, Michelle T. , Corey, Kathleen E. , Sallis, Robert E. , Allen, Alina M. , Armstrong, Matthew J. , Conroy, David E. , Duarte‐Rojo, Andrés , Hallsworth, Kate , Hickman, Ingrid J. , Pugh, Christopher J. A. , Simon, Tracey G. , Hallsworth, Kate , Hickman, Ingrid J , Kappus, Matthew R , Keating, Shelley E , Rotman, Yaron , Vilar-Gomez, Eduardo , Wong, Vincent Wai-Sun , Schmitz, Kathryn H , Long, Michelle T , Allen, Alina M , Corey, Kathleen , Duarte-Rojo, Andres , Cuthbertson, Daniel James , Kappus, Matthew R. , Rotman, Yaron , Vilar‐Gómez, Eduardo , Wong, Vincent Wai‐Sun , Schmitz, Kathryn H.

Hepatology Communications | March 30, 2023 | Volume: 7 | Issue: 4 | Pages: No page available

10.1097/hc9.0000000000000108 | PMID 36995998 Get It

Background and Aims: We present findings from the inaugural American College of Sports Medicine (ACSM) International Multidisciplinary Roundtable, which was convened to evaluate the evidence for physical activity as a means of preventing or modifying the course of NAFLD. Approach and Results: A scoping review was conducted to map the scientific literature and identify key concepts, research gaps, and evidence available to inform clinical practice, policymaking, and research. The scientific evidence demonstrated regular physical activity is associated with decreased risk of NAFLD development. Low physical activity is associated with a greater risk for disease progression and extrahepatic cancer. During routine health care visits, all patients with NAFLD should be screened for and counseled about physical activity benefits, including reduction in liver fat and improvement in body composition, fitness, and quality of life. While most physical activity benefits occur without clinically significant weight loss, evidence remains limited regarding the association between physical activity and liver fibrosis. At least 150 min/wk of moderate or 75 min/wk of vigorous-intensity physical activity are recommended for all patients with NAFLD. If a formal exercise training program is prescribed, aerobic exercise with the addition of resistance training is preferred. Conclusions: The panel found consistent and compelling evidence that regular physical activity plays an important role in preventing NAFLD and improving intermediate clinical outcomes. Health care, fitness, and public health professionals are strongly encouraged to disseminate the information in this report. Future research should prioritize determining optimal strategies for promoting physical activity among individuals at risk and in those already diagnosed with NAFLD.
AAPM task group report 305: Guidance for standardization of vendor‐neutral reject analysis in radiography
Little, Kevin J. , Reiser, Ingrid , Apgar, Bruce, Dave, Jaydev K. , Fisher, Ryan , Hulme, Katie, Jafari, Mary Ellen, Marshall, Emily L. , Meyer, Stephen, Moore, Quentin T , Murphy, Nicole, Nishino, Thomas K. , Nye, Katelyn, Sabol, John M. , Tarbox, Lawrence , Uzenoff, Robert, Walz‐Flannigan, Alisa , Willis, Charles E., Little, Kevin , Marshall, Emily , Nishino, Thomas , Sensakovic, William, Reiser, Ingrid , Dalal, Poonam, O'Donnell, Kevin, Sánchez, Adrian A. , Sensakovic, William F. , Zhang, Jie

Journal of Applied Clinical Medical Physics | March 30, 2023 | Volume: 24 | Issue: 5 | Pages: No page available

10.1002/acm2.13938 | PMID 36995917 Get It

AbstractReject rate analysis is considered an integral part of a diagnostic radiography quality control (QC) program. A rejected image is a patient radiograph that was not presented to a radiologist for diagnosis and that contributes unnecessary radiation dose to the patient. Reject rates that are either too high or too low may suggest systemic department shortcomings in QC mechanisms. Due to the lack of standardization, reject data often cannot be easily compared between radiography systems from different vendors. The purpose of this report is to provide guidance to help standardize data elements that are required for comprehensive reject analysis and to propose data reporting and workflows to enable an effective and comprehensive reject rate monitoring program. Essential data elements, a proposed schema for classifying reject reasons, and workflow implementation options are recommended in this task group report.